ClinicalTrials.Veeva

Menu
Novum Research, LLC | Clermont, FL logo

Novum Research, LLC | Clermont, FL

Research site

Site insights

Top conditions

Top treatments

Risankizumab
Duvakitug
SAR441566
Lutikizumab
Vedolizumab
Mirikizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

7 of 9 total trials
Locations recently updated

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease (STARSCAPE-2)

This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in p...

Enrolling
Crohn's Disease
Drug: Duvakitug
Drug: Placebo

The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severe...

Active, not recruiting
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Placebo
Drug: Eltrekibart

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the...

Active, not recruiting
Crohn's Disease
Drug: Placebo for risankizumab
Drug: Risankizumab SC

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large...

Active, not recruiting
Ulcerative Colitis
Drug: Risankizumab
Drug: Vedolizumab
Locations recently updated

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate...

Enrolling
Crohn's Disease
Drug: Duvakitug
Drug: Placebo
Locations recently updated

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of du...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: Duvakitug
Locations recently updated

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting...

Enrolling
Crohn's Disease
Drug: Trosunilimab
Drug: Risankizumab

Trial sponsors

Sanofi logo
AbbVie logo
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems